Immunic Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · New York, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1200 Avenue of the Americas Ste 200, New...Phone Number
(332) 255-9811Website
www.imux.comRevenue
-Stock Symbol
IMUXIndustry
About Immunic Therapeutics
Immunic Therapeutics is a clinical-stage biopharmaceutical company focused on developing selective oral immunology therapies for chronic inflammatory and autoimmune diseases. Their pipeline includes innovative treatments for conditions such as multiple sclerosis and celiac disease, aiming to provide high-quality, safe, and effective oral options for patients. The company targets patients suffering from serious chronic conditions, striving to address unmet medical needs and improve their quality of life. With a commitment to scientific innovation, Immunic Therapeutics seeks to transform bold research into real-world therapies that offer hope and better health outcomes.Explore more
Immunic Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Immunic Therapeutics
Compare insights from companies similar to Immunic Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Immunic Therapeutics Tech Stack
A closer look at the technologies used by Immunic Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Immunic Therapeutics
Sign Up For FreeTo access detailed company insights
Immunic Therapeutics is a clinical-stage biopharmaceutical company focused on developing selective oral immunology therapies for chronic inflammatory and autoimmune diseases. Their pipeline includes innovative treatments for conditions such as multiple sclerosis and celiac disease, aiming to provide high-quality, safe, and effective oral options fo... Read More
